O
OrbiMed’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203M | Buy |
15,518,492
+496,771
| +3% | +$6.51M | 5.08% | 4 |
|
|
2025
Q1 | $330M | Hold |
15,021,721
| – | – | 7.88% | 2 |
|
|
2024
Q4 | $401M | Hold |
15,021,721
| – | – | 8.25% | 1 |
|
|
2024
Q3 | $401M | Hold |
15,021,721
| – | – | 7.29% | 1 |
|
|
2024
Q2 | $271M | Hold |
15,021,721
| – | – | 5.34% | 3 |
|
|
2024
Q1 | $274M | Buy |
15,021,721
+454,545
| +3% | +$8.29M | 5.02% | 3 |
|
|
2023
Q4 | $159M | Hold |
14,567,176
| – | – | 3.18% | 6 |
|
|
2023
Q3 | $83.5M | Hold |
14,567,176
| – | – | 1.77% | 17 |
|
|
2023
Q2 | $113M | Hold |
14,567,176
| – | – | 2.05% | 11 |
|
|
2023
Q1 | $97.2M | Hold |
14,567,176
| – | – | 1.91% | 14 |
|
|
2022
Q4 | $130M | Hold |
14,567,176
| – | – | 2.49% | 9 |
|
|
2022
Q3 | $143K | Buy |
14,567,176
+484,496
| +3% | +$4.77K | 2.66% | 7 |
|
|
2022
Q2 | $112K | Buy |
14,082,680
+138,000
| +1% | +$1.1K | 2.03% | 13 |
|
|
2022
Q1 | $135M | Hold |
13,944,680
| – | – | 2.19% | 13 |
|
|
2021
Q4 | $213M | Hold |
13,944,680
| – | – | 2.74% | 6 |
|
|
2021
Q3 | $231M | Hold |
13,944,680
| – | – | 2.54% | 9 |
|
|
2021
Q2 | $297M | Hold |
13,944,680
| – | – | 3.01% | 3 |
|
|
2021
Q1 | $453M | Buy |
+13,944,680
| New | +$453M | 4.24% | 2 |
|